Genomic Health, Inc. (GHDX) financial statements (2022 and earlier)

Company profile

Business Address 301 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063
State of Incorp.
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:214,132129,57596,98994,943103,660105,35099,065
Cash and cash equivalents61,64545,51840,40432,53329,72633,27918,005
Short-term investments148,14984,05756,58562,41073,93472,07181,060
Other undisclosed cash, cash equivalents, and short-term investments4,338      
Receivables51,53131,16135,17937,16434,91629,44622,253
Prepaid expense and other current assets8,891
Other undisclosed current assets9,17313,52413,79610,8439,94410,196 
Total current assets:274,836174,260145,964142,950148,520144,992130,209
Noncurrent Assets
Property, plant and equipment39,53246,44045,68839,74621,86018,29014,104
Long-term investments and receivables4,066   13,90011,900 
Long-term investments4,066   13,90011,900 
Other noncurrent assets15,93810,9179,4621,92115,54113,752
Prepaid expense and other noncurrent assets9,421
Other undisclosed noncurrent assets    (13,900)(11,900) 
Total noncurrent assets:59,53657,35755,15041,66737,40132,04223,525
TOTAL ASSETS:334,372231,617201,114184,617185,921177,034153,734
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities59,17639,19340,94439,74635,33326,67822,663
Accounts payable8,8491562,8648,5856,9875,1604,881
Accrued liabilities15,87014,08410,1808,92210,4448,4646,340
Employee-related liabilities34,45724,95327,90022,23917,70812,77611,210
Taxes payable    194278232
Customer refund liability    944770664
Deferred revenue and credits  431335586374
Other liabilities600323231208208292243
Other undisclosed current liabilities   2,2871,5181,5061,396
Total current liabilities:59,77639,51641,17542,67238,33829,83225,340
Noncurrent Liabilities
Liabilities, other than long-term debt4,4363,8103,8342,4102,0702,2212,068
Other liabilities4,4363,8103,8342,4102,0702,2212,068
Total noncurrent liabilities:4,4363,8103,8342,4102,0702,2212,068
Total liabilities:64,21243,32645,00945,08240,40832,05327,408
Stockholders' equity
Stockholders' equity attributable to parent270,160188,291156,105139,535145,513144,981126,326
Common stock3333333
Treasury stock, value(30,110)(30,110)(30,110)(30,110)(30,110)(30,110)(30,095)
Additional paid in capital506,679464,637427,102395,059370,496345,345313,915
Accumulated other comprehensive income (loss)(87)(294)1,1982,752(15)1215
Accumulated deficit(206,325)(245,945)(242,088)(228,169)(194,861)(170,269)(157,512)
Total stockholders' equity:270,160188,291156,105139,535145,513144,981126,326
TOTAL LIABILITIES AND EQUITY:334,372231,617201,114184,617185,921177,034153,734

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues394,111340,750327,868287,458275,706261,595235,173
Revenue, net340,750327,868287,458275,706261,595235,173
Cost of revenue(49,341)(54,718)(57,263)(53,782)(48,742)(42,100)(37,018)
Cost of goods and services sold (54,718)(57,263)(53,782)(48,742)(42,100)(37,018)
Gross profit:344,770286,032270,605233,676226,964219,495198,155
Operating expenses(320,874)(292,482)(286,037)(267,703)(264,315)(243,827)(198,335)
Other undisclosed operating income    13,72412,5008,614
Operating income (loss):23,896(6,450)(15,432)(34,027)(23,627)(11,832)8,434
Nonoperating income (expense)2,1534,097(314)(277)(1,362)(94)191
Investment income, nonoperating2,3853,741418221192222295
Foreign currency transaction loss, before tax    (790)(158)(46)
Other nonoperating income (expense)(232)356(732)(498)(764)(158)(58)
Income (loss) from continuing operations before equity method investments, income taxes:26,049(2,353)(15,746)(34,304)(24,989)(11,926)8,625
Loss from equity method investments      (98)
Other undisclosed income (loss) from continuing operations before income taxes875 3,208 790(485)144
Income (loss) from continuing operations before income taxes:26,924(2,353)(12,538)(34,304)(24,199)(12,411)8,671
Income tax expense (benefit)(1,247)(1,504)(1,381)996(393)(346)(422)
Net income (loss) available to common stockholders, diluted:25,677(3,857)(13,919)(33,308)(24,592)(12,757)8,249

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):25,677(3,857)(13,919)(33,308)(24,592)(12,757)8,249
Comprehensive income (loss):25,677(3,857)(13,919)(33,308)(24,592)(12,757)8,249
Other undisclosed comprehensive income (loss), net of tax, attributable to parent27(1,492)(1,554)2,767(27)(3)45
Comprehensive income (loss), net of tax, attributable to parent:25,704(5,349)(15,473)(30,541)(24,619)(12,760)8,294

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: